California State Teachers Retirement System (CalSTRS)’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
BI
DTC
CAM
JT
LGM
WAM
California State Teachers Retirement System (CalSTRS)'s MLTX Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) increased its MoonLake Immunotherapeutics (MLTX) stake by 29% in Q2 2026, buying an estimated $155K and bringing the position to 37,839 shares worth $737K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.
California State Teachers Retirement System (CalSTRS) first reported a position in MLTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.03M in Q4 2024. 173 funds tracked by Wall St. Rank hold MLTX as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 37,839 shares of MoonLake Immunotherapeutics worth $737K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) bought 8,543 MoonLake Immunotherapeutics shares in Q2 2026, an estimated $155K.
- MoonLake Immunotherapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2059 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in MoonLake Immunotherapeutics in Q3 2023 and has held it in 12 quarters since.
- California State Teachers Retirement System (CalSTRS)'s MoonLake Immunotherapeutics position peaked at $1.03M in Q4 2024.
- 173 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.